A 2009 study reported the design, construction and selection of a phage-encoded bicyclic peptide library that used a chemical linker for cyclization. This and other advanced display technologies ...

In a recent study published in the Journal of the American Chemical Society, researchers present the second-generation NTB bicyclic stereodiversified peptide library. Study: MYC-Targeting ...

Bicycle's bicyclic peptide drug discovery platform is designed to produce drug candidates that have targeting properties like antibodies but are much smaller molecules, making manufacturing and ...

More information: Zhonghan Li et al, MYC-Targeting Inhibitors Generated from a Stereodiversified Bicyclic Peptide Library, Journal of the American Chemical Society (2024). DOI: 10.1021/jacs.

Bicycle Therapeutics has developed a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle) product platform, and will gain funding for phase 1 and phase 1b clinical trial ...

BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the presentation of data ...

BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle ®) technology, today announced the appointment of ...

BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle ®) technology, today announced that management will ...

INR:3704. rummy you download Can’t the problem of bribery and drug kickbacks by many well-known pharmaceutical companies such as China Resources Sanjiu be st ...